MedTrace Logo

STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture

NCT03268356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2022-11-30

No results posted yet for this study

Summary

To evaluate the procedure and safety profile of the AGN1 Femoral LOEP Kit. This pilot study will be used to evaluate AGN1 Femoral LOEP treatment in a contralateral proximal femur during hip fracture repair.

Conditions

  • Hip Fractures
  • Osteoporosis, Postmenopausal

Interventions

DEVICE

AGN1 Femoral Local Osteo-Enhancement Procedure Kit

A procedure that is intended to replace lost bone and increase the strength of the proximal femur in individuals with osteoporosis of the femoral neck.

Sponsors & Collaborators

  • AgNovos Healthcare, LLC

    lead INDUSTRY

Principal Investigators

  • Christian Fang, MD · Queen Mary Hospital, Hong Kong

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03268356 on ClinicalTrials.gov